In humans, mutations of the SATB2 gene cause SATB2 Associated Syndrome (SAS) and are characterized by symptoms such as developmental delay (DD)/ intellectual disability (ID), epilepsy, absent or limited speech development, craniofacial abnormalities including palatal and dental abnormalities, dysmorphic features and behavior12–15. The gene discussed is SATB2; the disease is epilepsy.